Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lamb

Showing results (41-50 of 244) with videos related to

Pageof 25
Sort By:
Drugs|December 1, 2024
Correction: Vorasidenib: First ApprovalYvette N Lamb
Targeted Oncology|September 26, 2021
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLCYvette N Lamb
Drugs|March 19, 2022
Nirmatrelvir Plus Ritonavir: First ApprovalYvette N Lamb
Paediatric Drugs|October 28, 2021
Lonapegsomatropin: Pediatric First ApprovalYvette N Lamb
Drugs|October 12, 2019
Pexidartinib: First ApprovalYvette N Lamb
Drugs|April 13, 2021
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Drugs|September 2, 2021
Imeglimin Hydrochloride: First ApprovalYvette N Lamb
Drugs|June 22, 2025
Recaticimab: First ApprovalYvette N Lamb
Drugs|June 23, 2025
Tiratricol: First ApprovalYvette N Lamb
Drugs|December 23, 2024
Marstacimab: First ApprovalYvette N Lamb
Pageof 25

Showing results (41-50 of 244) with videos related to

Sort By:
Pageof 25
Drugs|December 1, 2024
Correction: Vorasidenib: First ApprovalYvette N Lamb
Targeted Oncology|September 26, 2021
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLCYvette N Lamb
Drugs|March 19, 2022
Nirmatrelvir Plus Ritonavir: First ApprovalYvette N Lamb
Paediatric Drugs|October 28, 2021
Lonapegsomatropin: Pediatric First ApprovalYvette N Lamb
Drugs|October 12, 2019
Pexidartinib: First ApprovalYvette N Lamb
Drugs|April 13, 2021
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung DiseasesYvette N Lamb
Drugs|September 2, 2021
Imeglimin Hydrochloride: First ApprovalYvette N Lamb
Drugs|June 22, 2025
Recaticimab: First ApprovalYvette N Lamb
Drugs|June 23, 2025
Tiratricol: First ApprovalYvette N Lamb
Drugs|December 23, 2024
Marstacimab: First ApprovalYvette N Lamb
Pageof 25